Deciphering the Multifaceted Immune Landscape of Unresectable Primary Liver Cancer to Predict Immunotherapy Response
2024

Understanding the Immune Landscape of Liver Cancer for Better Immunotherapy

Sample size: 77 publication 10 minutes Evidence: high

Author Information

Author(s): Xue Jun, Yang Shuai, Zhang Si‐Si, Fan Jun, Wu Zi‐Long, Sui Cheng‐Jun, Yang Yong‐Qiang, Zhang Jin‐Feng, Liu Pian, Zhang De‐Jun, Qiu Xin‐Yao, Zhang Tao, Chen Lei, Wu Gang, Wang Hong‐Yang, Tang Jing

Primary Institution: Huazhong University of Science and Technology

Hypothesis

Can the immune characteristics of patients with unresectable primary liver cancer predict their response to immunotherapy?

Conclusion

The study identifies specific immune cell profiles that can help predict which liver cancer patients will respond to immunotherapy.

Supporting Evidence

  • Responders had lower baseline B cell and HLA-DR+CD8+T cell proportions.
  • Classical monocytes decreased more in responders after treatment.
  • Responders showed higher enrichment of B cells in tumors compared to non-responders.
  • A predictive model achieved a satisfactory AUC over 0.9 in independent cohorts.
  • Dynamic changes in immune cell populations can indicate treatment response.

Takeaway

Doctors can look at certain immune cells in the blood of liver cancer patients to guess if their treatment will work.

Methodology

The study used single-cell mass cytometry and immunohistochemistry to analyze immune cells from blood and tumor samples of liver cancer patients.

Potential Biases

Potential biases may arise from the small sample size and the heterogeneity of the patient population.

Limitations

The study had a relatively small sample size and included different types of liver cancer, which may affect the results.

Participant Demographics

The study included 77 patients with unresectable primary liver cancer, primarily hepatocellular carcinoma.

Statistical Information

P-Value

0.039

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1002/advs.202309631

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication